<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712454217</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712454217</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Diseases</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Differences in Clinical Profile of Individuals With Severe and Markedly Elevated Coronary Artery Calcification Detected by Electron Beam Computed Tomography</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Koulaouzidis</surname>
<given-names>G.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712454217">1</xref>
<xref ref-type="aff" rid="aff3-0003319712454217">3</xref>
<xref ref-type="corresp" rid="corresp1-0003319712454217"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Charisopoulou</surname>
<given-names>D.</given-names>
</name>
<degrees>MD, BSc, FRCPCH</degrees>
<xref ref-type="aff" rid="aff2-0003319712454217">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maffrett</surname>
<given-names>S.</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff3-0003319712454217">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tighe</surname>
<given-names>M.</given-names>
</name>
<degrees>DCR</degrees>
<xref ref-type="aff" rid="aff3-0003319712454217">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jenkins</surname>
<given-names>P. J.</given-names>
</name>
<degrees>MD, FRCP</degrees>
<xref ref-type="aff" rid="aff3-0003319712454217">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McArthur</surname>
<given-names>T.</given-names>
</name>
<degrees>DCR</degrees>
<xref ref-type="aff" rid="aff3-0003319712454217">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712454217">
<label>1</label>Heart Centre and Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden</aff>
<aff id="aff2-0003319712454217">
<label>2</label>Royal Brompton and Harefield NHS Foundation Trust, London, UK</aff>
<aff id="aff3-0003319712454217">
<label>3</label>European Scanning Centre, London, UK</aff>
<author-notes>
<corresp id="corresp1-0003319712454217">George Koulaouzidis, Heart Centre and Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden. Email: <email>geokoul@hotmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>6</issue>
<fpage>435</fpage>
<lpage>439</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Although several studies have demonstrated the association between coronary artery calcification (CAC) and coronary artery disease events, the underlying mechanism has not been fully elucidated. Furthermore, extensive CAC still remains a poorly understood phenomenon. The objective of this study is to determine the clinical characteristics and differences between 831 asymptomatic individuals with very high CAC scores (CACS ≥1000) and 497 asymptomatic individuals with CAC scores of 400 to 999. Individuals with CACS ≥1000 were more likely to have hypertension ([HTN]; <italic>P = </italic>.0004), hypercholesterolemia (<italic>P = </italic>.0001), diabetes mellitus ([DM] <italic>P = </italic>.005), and high body mass index ([BMI]; <italic>P = </italic>.03) compared with individuals with CACS = 400-999. On multivariable analysis, age (<italic>P </italic>&lt; .0001) and BMI (<italic>P </italic>= .01) were found to be significant risk factors for the presence of very high CAC. While for males, age (<italic>P </italic>&lt; .0001), hypercholesterolemia (<italic>P </italic>= .001), DM (<italic>P </italic>= .002), and obesity (<italic>P </italic>= .003) were independent risk factors; in females only HTN (<italic>P </italic>= .04) was independent risk factor.</p>
</abstract>
<kwd-group>
<kwd>coronary artery calcification</kwd>
<kwd>coronary artery calcium score</kwd>
<kwd>electron beam computed tomography</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319712454217">
<title>Introduction</title>
<p>The process of atherosclerosis begins early in life and progresses silently until clinical symptoms develop at later stages.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712454217">1</xref>
</sup> Early detection of asymptomatic coronary atherosclerosis remains a desirable but challenging target. Pathologoanatomic studies have demonstrated that coronary calcium quantification can be an effective and reliable marker of the presence of atherosclerotic plaque.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712454217">2</xref>
<xref ref-type="bibr" rid="bibr3-0003319712454217"/>–<xref ref-type="bibr" rid="bibr4-0003319712454217">4</xref>
</sup> Moreover, coronary artery calcification (CAC) is widely accepted as a strong independent risk factor and predictor of coronary artery disease (CAD) events.<sup>
<xref ref-type="bibr" rid="bibr5-0003319712454217">5</xref>
<xref ref-type="bibr" rid="bibr6-0003319712454217"/>
<xref ref-type="bibr" rid="bibr7-0003319712454217"/>
<xref ref-type="bibr" rid="bibr8-0003319712454217"/>–<xref ref-type="bibr" rid="bibr9-0003319712454217">9</xref>
</sup>
</p>
<p>Despite the well-established association between the extent of CAC and CAD events, the mechanisms of extensive CAC development remain poorly understood. Extensive CAC may represent the end stage of atherosclerosis or may indicate an early defense mechanism against complications of atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr10-0003319712454217">10</xref>
<xref ref-type="bibr" rid="bibr11-0003319712454217"/>–<xref ref-type="bibr" rid="bibr12-0003319712454217">12</xref>
</sup> The clinical characteristics and the prognostic role between patients with markedly elevated CAC and severe CAC have not been fully evaluated yet. Wayhs et al followed up a cohort of 99 asymptomatic individuals with CACS ≥1000 for a period of 17 ± 11 months and reported that the annual absolute rate for myocardial infarction (MI) or CAD-related death was 25%.<sup>
<xref ref-type="bibr" rid="bibr13-0003319712454217">13</xref>
</sup> In parallel, Budoff et al in a cohort of 25 253 asymptomatic individuals, noted that the 10-year survival was 87.8% in individuals with CACS &gt;1000.<sup>
<xref ref-type="bibr" rid="bibr14-0003319712454217">14</xref>
</sup> Conversely, in a subcohort of the Multi-Ethnic Study of Atherosclerosis (MESA), markedly elevated CAC was associated with an increased risk of angina but not CAD death or MI, compared with high CAC.<sup>
<xref ref-type="bibr" rid="bibr15-0003319712454217">15</xref>
</sup>
</p>
<p>We focused on extensive CAC, where the CACS is &gt;400 and can be as high as 6000. Wayhs et al demonstrated that a CACS &gt;1000 will be useful additional threshold for clinical risk assessment.<sup>
<xref ref-type="bibr" rid="bibr13-0003319712454217">13</xref>
</sup> Until now, little is known about the distinction between individuals with high CAC and very high CAC. The aim of the present study is to investigate possible differences in the clinical profile between individuals with severe (high) CAC, that is, CACS = 400 to 999 and extensive (very high) CAC, that is, CACS ≥1000.</p>
</sec>
<sec id="section2-0003319712454217" sec-type="methods">
<title>Methods</title>
<sec id="section3-0003319712454217">
<title>Data Collection</title>
<p>Between January 2002 and December 2009, 16 247 asymptomatic men and women aged 22 to 89 years underwent electron beam computed tomography (EBCT), as part of a preventive health examination or because of physician referral. Using this database, we selected consecutive individuals with CACS between 400 and 999 and individuals with CACS ≥1000. Demographic information and the presence of risk factors were abstracted from referral letters and questionnaires completed by the patients prior to their test. Individuals with previously documented CAD or chronic kidney disease (CKD) were excluded from the study. Chronic kidney disease was defined as decreased glomerular filtration rate of less than 60 mL/min per 1.73 m<sup>2</sup> for 3 or more months.</p>
</sec>
<sec id="section4-0003319712454217">
<title>Computed Tomography Scanning</title>
<p>All EBCT CAC studies were performed using the same scanner (Imatron C300 Ultrafast computed tomography scanner, GE Healthcare, London, UK) and the same scan protocol. Forty contiguous, 3-mm-thick slices were obtained during a single breath hold, beginning at the lower edge of the carina. The field of view was 26 cm, and the scan time was 100 ms per slice, with synchronized electrocardiographic triggering at 80% of the RR interval. At least 2 adjacent pixels (ie, area ≥0.93 mm<sup>2</sup>) with a density &gt;130 Hounsfield units were required to define a lesion. The CACS were calculated according to the method proposed by Agatston et al<sup>
<xref ref-type="bibr" rid="bibr16-0003319712454217">16</xref>
</sup> A single investigator reviewed all EBCT studies and confirmed the CACS. Measure of intrareader scoring variability was not considered as necessary; because the latter is negligible with CACS in the range we selected.<sup>
<xref ref-type="bibr" rid="bibr17-0003319712454217">17</xref>
</sup>
</p>
<p>All patients had given a written consent for the test and for their clinical data to be used for research purposes. The study did not require specific ethics approval since it was based on clinically obtained information.</p>
</sec>
<sec id="section5-0003319712454217">
<title>Risk Factors</title>
<p>For the purpose of this study, hypertension (HTN) was defined as the use of antihypertensive medication or known but untreated HTN. Dyslipidemia was defined as the use of cholesterol-lowering medications or having known but untreated total serum cholesterol &gt;240 mg/dL (6.2 mmol/L). Diabetes mellitus (DM) was defined as a fasting plasma glucose level of at least 126 mg/dL (7.0 mmol/L), use of hypoglycemic medication or self-reported previous physician diagnosis. The body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters. Obesity was defined as BMI ≥30. Family history of CAD was obtained by asking the participants whether any first-degree relative (men &lt;55 years and women &lt;65 years) had had a fatal or nonfatal MI, coronary angioplasty, or coronary artery bypass surgery. Current smokers and those who stopped smoking fewer than 30 days prior to the CT scan were included in the smoking category, whereas the remainder were characterized as nonsmokers.</p>
</sec>
</sec>
<sec id="section6-0003319712454217">
<title>Statistical Analysis</title>
<p>Results are presented as mean ± standard deviations. Continuous variables were compared using Student <italic>t</italic> test and categorical variables were compared using Pearson χ<sup>
<xref ref-type="bibr" rid="bibr2-0003319712454217">2</xref>
</sup> test. Associations between risk factors and CAC categories (high = 400-999 and extensive &gt;1000) were examined using logistic regression analysis. In a multivariable model, we entered the CACS and cardiovascular risk factors and computed regression coefficients for CACS and all entered cardiovascular risk factors. All tests were 2 tailed, and a <italic>P</italic> &lt; .05 was considered significant.</p>
</sec>
<sec id="section7-0003319712454217">
<title>Results</title>
<p>Of the 16 247 examined individuals, 831 (5.11%) had high CACS and 497 (3.05%) very high CACS. The median CACS for high CAC was 604 (range: 401-997) and the median CACS for very high CACS was 1538 (range: 1001-7908). <xref ref-type="table" rid="table1-0003319712454217">Table 1</xref> shows the clinical characteristics of the study population. Individuals with very high CACS were older (64.4 vs 61.2, <italic>P </italic>= .0001) than those with high CACS. Between the 2 cohorts (high CACS vs very high CACS), there were no differences in gender (89.6% males in high CAC vs 90.1% males in very high CACS; <italic>P </italic>= .85) and racial/ethnic composition (86.4% Caucasians in high CACS vs 90.1% in very high CACS).</p>
<table-wrap id="table1-0003319712454217" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical Characteristics of Participants With High CAC (400-999) Versus Very High (extensive) CAC (≥1000), Mean, SD, or Prevalence.</p>
</caption>
<graphic alternate-form-of="table1-0003319712454217" xlink:href="10.1177_0003319712454217-table1.tif"/>
<table>
<thead>
<tr>
<th>Clinical Characteristics</th>
<th>High CAC (400-999), N = 831</th>
<th>Very High (≥1000), N = 497 </th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years (SD)</td>
<td>61.2 (8.1)</td>
<td>64.4 (8.24)</td>
<td>.0001</td>
</tr>
<tr>
<td>Gender, male, n (%)</td>
<td>745 (89.65)</td>
<td>448 (90.14)</td>
<td>.85</td>
</tr>
<tr>
<td>Family history of CAD, n (%)</td>
<td>259 (31.16)</td>
<td>146 (29.37)</td>
<td>.5</td>
</tr>
<tr>
<td>Hypertension, n (%)</td>
<td>323 (38.86)</td>
<td>243 (48.9)</td>
<td>.0004</td>
</tr>
<tr>
<td>Hypercholesterolemia, n (%)</td>
<td>509 (38.75)</td>
<td>244 (48.1)</td>
<td>.0001</td>
</tr>
<tr>
<td>Diabetes mellitus, n (%)</td>
<td>105 (12.63)</td>
<td>91 (18.31)</td>
<td>.005</td>
</tr>
<tr>
<td>Smoking, n (%)</td>
<td>99 (11.91)</td>
<td>74 (14.9)</td>
<td>.13</td>
</tr>
<tr>
<td>BMI: mean (SD)</td>
<td>26.75 (4.4)</td>
<td>27.55 (4.2)</td>
<td>.03</td>
</tr>
<tr>
<td>Obesity, BMI ≥30 kg/m<sup>2</sup>, n (%)</td>
<td>180 (21.66)</td>
<td>139 (27.76)</td>
<td>.014</td>
</tr>
<tr>
<td>Ethinicty</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Caucasian</td>
<td>718 (86.4)</td>
<td>429 (86.3)</td>
<td>.5</td>
</tr>
<tr>
<td> South Asian</td>
<td>61 (7.4)</td>
<td>43 (8.7)</td>
<td>
</td>
</tr>
<tr>
<td> African</td>
<td>4 (0.5)</td>
<td>2 (0.4)</td>
<td>
</td>
</tr>
<tr>
<td> Other</td>
<td>48 (5.8)</td>
<td>22 (5.1)</td>
<td>
</td>
</tr>
<tr>
<td>&gt;2 risk factors</td>
<td>264 (31.76)</td>
<td>388 (78.1)</td>
<td>.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319712454217">
<p>Abbreviations: CAC, coronary artery calcification; CAD, coronary artery disease; BMI, body mass index; SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Comparing the clinical profile of patients with very high CAC with that of high CACS differences in the frequency of HTN (48.9% vs 38.86%, <italic>P </italic>= .0004), hypercholesterolemia (48.1% vs 38.75%, <italic>P </italic>= .0001), DM (18.3% vs 12.63%, <italic>P </italic>= .005), and obesity (27.76% vs 21.66%, <italic>P </italic>= .03) were recorded. More than 2 risk factors were present in 502 (60.4%) of 831 individuals with high CACS and 367 (73.8%) of individuals with very high CACS; <italic>P </italic>&lt; .001. There were no individuals free of risk factors in both cohorts. On multivariable analysis, age and obesity were independent predictors of very high CACS (<xref ref-type="table" rid="table2-0003319712454217">Table 2</xref>).</p>
<table-wrap id="table2-0003319712454217" position="float">
<label>Table 2.</label>
<caption>
<p>Multivariable-Adjusted Regression Coefficients Between CAD Risk Factors and High CAC (400-999) Compared With Very High CAC (≥1000).</p>
</caption>
<graphic alternate-form-of="table2-0003319712454217" xlink:href="10.1177_0003319712454217-table2.tif"/>
<table>
<thead>
<tr>
<th>Clinical Characteristics</th>
<th>Regression Coefficients (95% CI)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>0.01 (0.01, 0.02)</td>
<td>.0001</td>
</tr>
<tr>
<td>Gender (male)</td>
<td>0.05 (−0.07, 0.17)</td>
<td>.4</td>
</tr>
<tr>
<td>Family history of CAD</td>
<td>0.04 (−0.03, 0.12)</td>
<td>.2</td>
</tr>
<tr>
<td>Hypertension</td>
<td>0.04 (−0.03, 0.12)</td>
<td>.3</td>
</tr>
<tr>
<td>Hypercholesterolemia</td>
<td>0.07 (−0.05, 0.14)</td>
<td>.07</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>0.07 (−0.04, 0.19)</td>
<td>.2</td>
</tr>
<tr>
<td>Smoking</td>
<td>0.09 (−0.01, 0.2)</td>
<td>.09</td>
</tr>
<tr>
<td>Obesity</td>
<td>0.01 (0.002, 0.2)</td>
<td>.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0003319712454217">
<p>Abbreviations: CAC, coronary artery calcification; CAD, coronary artery disease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Similar results were found when the male subcohort was examined (<xref ref-type="table" rid="table3-0003319712454217">Table 3</xref>); males with very high CACS had significantly higher prevalence of HTN (48.4% vs 37.5%, <italic>P </italic>= .002), hypercholesterolemia (48.6% vs 39.9%, <italic>P </italic>= .001), DM (19.2% vs 12.34%, <italic>P </italic>= .002), and obesity (28.8% vs 21.2%, <italic>P </italic>= .003) compared with males with simply high CACS. Furthermore, the average age of males with very high CACS was significantly higher than that of males with high CACS (60.8 ± 7.9 vs 64.2 ± 8, <italic>P </italic>&lt; .0001). Moreover, 79.5% of males with very high CACS had &gt;2 risk factors compared with 70% of males with high CAC. On multivariable analysis, age, obesity, and hypercholesterolemia are independent predictors of very high CACS (<xref ref-type="table" rid="table4-0003319712454217">Table 4</xref>).</p>
<table-wrap id="table3-0003319712454217" position="float">
<label>Table 3.</label>
<caption>
<p>Clinical Characteristics of Males and Females With High CAC (400-999) Versus Very High (Extensive) CAC (≥1000); Mean, SD, or Prevalence.</p>
</caption>
<graphic alternate-form-of="table3-0003319712454217" xlink:href="10.1177_0003319712454217-table3.tif"/>
<table>
<thead>
<tr>
<th>Clinical Characteristics</th>
<th>MALE CACS 400-999, n = 745</th>
<th>CACS ≥ 1000, n = 448 </th>
<th>
<italic>P</italic>
</th>
<th>Female CACS 400-999, n = 86</th>
<th>CACS ≥ 1000, n = 49</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years (SD) </td>
<td>60.8 (7.9)</td>
<td>64.2 (8)</td>
<td>.0001</td>
<td>64.8 (8.7)</td>
<td>66 (9.9)</td>
<td>.44</td>
</tr>
<tr>
<td>Family history of CAD, n (%)</td>
<td>218 (29.7) </td>
<td>125 (27.9) </td>
<td>.64</td>
<td>41 (47.7) </td>
<td>22 (44.9) </td>
<td>.86 </td>
</tr>
<tr>
<td>Hypertension, n (%)</td>
<td>279 (37.5)</td>
<td>217 (48.4)</td>
<td>.002</td>
<td>45 (52.3)</td>
<td>26 (53.1)</td>
<td>1.00</td>
</tr>
<tr>
<td>Hypercholesterolemia, n (%)</td>
<td>290 (39.9)</td>
<td>218 (48.6)</td>
<td>.001</td>
<td>33 (38.4)</td>
<td>27 (55.1)</td>
<td>.07</td>
</tr>
<tr>
<td>Diabetes mellitus, n (%) </td>
<td>92 (12.34)</td>
<td>86 (19.2)</td>
<td>.002</td>
<td>13 (15.1)</td>
<td>5 (10.2)</td>
<td>.6</td>
</tr>
<tr>
<td>Smoking, n (%) </td>
<td>82 (11)</td>
<td>64 (14.3)</td>
<td>.1</td>
<td>10 (20.5)</td>
<td>17 (19.8)</td>
<td>1.00</td>
</tr>
<tr>
<td>BMI: mean (SD) </td>
<td>29.9 (4.3) </td>
<td>27.7 (4) </td>
<td>.02</td>
<td>25.6 (5.2) </td>
<td>26.1 (5.4) </td>
<td>.65 </td>
</tr>
<tr>
<td>Obesity, BMI ≥30 kg/m<sup>2</sup>, n (%)</td>
<td>158 (21.2)</td>
<td>129 (28.8)</td>
<td>.003</td>
<td>28 (32.5)</td>
<td>10 (20.5)</td>
<td>.16</td>
</tr>
<tr>
<td>&gt;2 risk factors </td>
<td>522 (70)</td>
<td>356 (79.5)</td>
<td>.0004</td>
<td>44 (51.2)</td>
<td>17 (65.3)</td>
<td>.07</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0003319712454217">
<p>Abbreviations: CAC, coronary artery calcification; CAD, coronary artery disease; BMI, body mass index; SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Conversely, these differences were not observed in the female subcohort. Significant difference in the prevalence of hypercholesterolemia (55.1% of females with high CACS vs 38.4% with high CACS; <italic>P </italic>= .07) and the prevalence of &gt;2 risk factors (65.3% in females with very high CACS vs 51.2% with high CACS; <italic>P </italic>= .07) were identified. On multivariable analysis, HTN remained independent predictor of very high CACS (<xref ref-type="table" rid="table4-0003319712454217">Table 4</xref>).</p>
<table-wrap id="table4-0003319712454217" position="float">
<label>Table 4.</label>
<caption>
<p>Multivariable-Adjusted Regression Coefficients Between CAD Risk Factors and High CAC (400-999) Compared With Very High CAC (≥ 1000) in Male and Female Cohorts.</p>
</caption>
<graphic alternate-form-of="table4-0003319712454217" xlink:href="10.1177_0003319712454217-table4.tif"/>
<table>
<thead>
<tr>
<th>Clinical Characteristics</th>
<th>Regression Coefficients (95% CI), Male</th>
<th>
<italic>P</italic>
</th>
<th>Regression Coefficients (95% CI), Female</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>0.016 (0.011, 0.021)</td>
<td>&lt;.0001</td>
<td>0.01 (−0.004, 0.027)</td>
<td>.155</td>
</tr>
<tr>
<td>Family history of CAD </td>
<td>0.065 (−0.022, 0.154)</td>
<td>.145</td>
<td>−0.118 (−0.438, 0.2)</td>
<td>.458</td>
</tr>
<tr>
<td>Hypertension</td>
<td>0.088 (−0.001, 0.177)</td>
<td>.051</td>
<td>−0.358 (−0.706, −0.011)</td>
<td>.043</td>
</tr>
<tr>
<td>Hypercholesterolemia</td>
<td>0.091 (0.039, 0.178)</td>
<td>.04</td>
<td>−0.056 (−0.354, 0.241)</td>
<td>.706</td>
</tr>
<tr>
<td>Diabetes mellitus </td>
<td>0.075 (0.061, −0.044)</td>
<td>.217</td>
<td>−0.020 (−0.473, 0.432)</td>
<td>.926</td>
</tr>
<tr>
<td>Smoking</td>
<td>0.112 (−0.008, 0.234)</td>
<td>.069</td>
<td>−0.484 (−0.4299, 0.333)</td>
<td>.799</td>
</tr>
<tr>
<td>Obesity</td>
<td>0.014 (0.004, 0.024)</td>
<td>.003</td>
<td>0.004 (−0.023, 0.031)</td>
<td>.759</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0003319712454217">
<p>Abbreviations: CAC, coronary artery calcification; CAD, coronary artery disease; CI, confidence interval.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-0003319712454217">
<title>Discussion</title>
<p>Our retrospective study provides new information about how gender and risk factors for CAD influence CAC in asymptomatic individuals with CACS &gt; 400 but without CKD or CAD. Very high CAC indicates extensive coronary atherosclerosis and is associated with significant luminal stenosis. Almeda et al reported that CACS ≥1000 is associated with increased age and an increased likelihood of coronary stenosis ≥50% on coronary angiography.<sup>
<xref ref-type="bibr" rid="bibr18-0003319712454217">18</xref>
</sup> Moreover, extensive CAC is likely associated with increased risk of interventional complications and suboptimal coronary stent expansion compared with fibrocellular plaques.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712454217">19</xref>
<xref ref-type="bibr" rid="bibr20-0003319712454217"/>–<xref ref-type="bibr" rid="bibr21-0003319712454217">21</xref>
</sup> Also, trials did not demonstrate any effect of statins on the progression of calcification.<sup>
<xref ref-type="bibr" rid="bibr22-0003319712454217">22</xref>
</sup>
</p>
<p>Conversely, extensive or very high CAC is associated with more invasive testing and higher costs compared with lower levels of CAC.<sup>
<xref ref-type="bibr" rid="bibr23-0003319712454217">23</xref>
</sup> On the other hand, extensive calcification may play a protective role against complications (eg, aneurysm formation and plaque rupture) or even against acute coronary syndromes.<sup>
<xref ref-type="bibr" rid="bibr24-0003319712454217">24</xref>
</sup> Investigating extensive calcification is still at its early stages and little is known to date about the differences among those with high (CACS = 400-999) and very high CAC (CACS ≥1000).</p>
<p>In the present retrospective study, we showed that individuals with CACS ≥1000 were more likely to have HTN (<italic>P </italic>= .0004), hypercholesterolemia (<italic>P = </italic>.0001), DM (<italic>P </italic>= .005), and high BMI (<italic>P </italic>= .03) compared with those with simply high CAC (CACS = 400-999). On multivariable analysis, age, BMI, and hypercholesterolemia were found to be independent predictor of very high CAC.</p>
<p>Furthermore, our results demonstrated a gender variation as far as it regards the extensive CAC risk factors. In males, age (<italic>P </italic>&lt; .0001), hypercholesterolemia (<italic>P </italic>= .001), and obesity (<italic>P </italic>= .003) were independent predictor of extensive CAC, while in female subcohort only HTN (<italic>P</italic> = .04) featured as predictor of CAC.</p>
<p>Coylewright et al<sup>
<xref ref-type="bibr" rid="bibr15-0003319712454217">15</xref>
</sup> studied 257 participants with very high CAC and 420 with high CAC (participant subgroups of MESA) and found that very high CAC compared with high CAC was associated with male gender and older age. In contrast to our results, they did not find any gender variation in risk factors between the 2 groups. This can be explained by the different demographic characteristics between Coylewright’s<sup>
<xref ref-type="bibr" rid="bibr15-0003319712454217">15</xref>
</sup> population and ours, such as the ethnic composition of the studied groups. The majority of our patients were Caucasians, whereas in the MESA study Caucasians were only half of the participants. Also, they reported that CKD was associated with very high CAC; with a greater prevalence of moderate CKD in group of very high CAC compared to group of high CAC. In our study, CKD was one of the exclusion criteria, so the association between CAC and renal disease was not studied.</p>
<p>At least 50% of the 1 000 000 MIs occurring annually represent the first cardiovascular event in people without known history of CAD.<sup>
<xref ref-type="bibr" rid="bibr25-0003319712454217">25</xref>
</sup> Therefore, measuring CAC is a valuable tool in the risk assessment of appropriately selected individuals. In our study, we have shown that asymptomatic individuals, especially older in age men, with more than 2 risk CAD factors may benefit from CAC measurements, while CT coronary angiography would be more appropriate in symptomatic persons.<sup>
<xref ref-type="bibr" rid="bibr26-0003319712454217">26</xref>
<xref ref-type="bibr" rid="bibr27-0003319712454217"/>–<xref ref-type="bibr" rid="bibr28-0003319712454217">28</xref>
</sup>
</p>
<p>The management of the asymptomatic patient with CAD presents a significant challenge for cardiologists. As the presence of CACS ≥1000 is associated with increased likelihood of stenosis &gt;50% and a very high risk for MI or coronary death, patients with such high scores deserve aggressive medical management and further diagnostic investigation. However, the decision for coronary angiography should not be based only on EBCT findings but additionally on appropriate functional test results.</p>
<p>The present study is the first large study in asymptomatic Caucasians with no known CAD or CKD and very high CAC. Our findings suggested that individuals with very high CAC are more likely to be older, with high BMI. After multivariable analysis, in female cohort only HTN was independent factor while in male cohort age, obesity, and hypercholesterolemia had significant association with very high CAC. The patients are considered exclusively for clinical characteristics, but nothing is known about their outcomes (coronary artery bypass graft and myocardial revascularization). However, providing results about outcome may improve the scientific interest of the article contributing to clarify the role of coronary calcification on CAD.</p>
<sec id="section9-0003319712454217">
<title>Limitations</title>
<p>This is a retrospective, single-center study. We believe, however, that risk factors were accurately documented by the referring physician or the CT scan supervising physician. The duration of individual risk factors and the treatment details which may have helped to explain some of the differences between the 2 groups were not available. A potential limitation of our study is the fact that the genders are not equally represented in the 2 cohorts, with the majority of the patients being male (89.6% in the group with high CAC and 90.1% in the group with very high CAC). This may be due to the fact that CAC score has been shown to be strongly associated with male gender.<sup>
<xref ref-type="bibr" rid="bibr29-0003319712454217">29</xref>
<xref ref-type="bibr" rid="bibr30-0003319712454217"/>–<xref ref-type="bibr" rid="bibr31-0003319712454217">31</xref>
</sup>
</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Dr Anastasios Koulaouzidis for his useful comments in manuscript preparation.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319712454217">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319712454217">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712454217">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubin</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Borden</surname>
<given-names>WB</given-names>
</name>
</person-group>. <article-title>Coronary heart disease in young adults</article-title>. <source>Curr Atheroscler Rep</source>. <year>2012</year>;<volume>14</volume>(<issue>2</issue>):<fpage>140</fpage>–<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712454217">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rumberger</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Sheedy</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>RS</given-names>
</name>
</person-group>. <article-title>Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study</article-title>. <source>Circulation</source>. <year>1995</year>;<volume>92</volume>(<issue>8</issue>):<fpage>2157</fpage>–<lpage>2162</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712454217">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mautner</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Maunter</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Froehlich</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation</article-title>. <source>Radiology</source>. <year>1994</year>;<volume>192</volume>(<issue>3</issue>):<fpage>619</fpage>–<lpage>623</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712454217">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanenbaum</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Kondos</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Veselik</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Prendergast</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Brundage</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Chomka</surname>
<given-names>EV</given-names>
</name>
</person-group>. <article-title>Detection of calcific deposits in coronary arteries by ultrafast computed tomography and correlation with angiography</article-title>. <source>Am J Cardiol</source>. <year>1989</year>;<volume>63</volume>(<issue>12</issue>):<fpage>870</fpage>–<lpage>872</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712454217">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sangiorgi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rumberger</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Severson</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Arterial calcification and not lumen stenosis is correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology</article-title>. <source>J Am Coll Cardiol</source>. <year>1998</year>;<volume>31</volume>(<issue>1</issue>):<fpage>126</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712454217">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breen</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Sheedy</surname>
<given-names>PF</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Schwartz</surname>
<given-names>RS</given-names>
</name>
<etal/>
</person-group>. <article-title>Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease</article-title>. <source>Radiology</source>. <year>1992</year>;<volume>185</volume>(<issue>2</issue>):<fpage>435</fpage>–<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712454217">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arad</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Spadaro</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Newstein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guerci</surname>
<given-names>AD</given-names>
</name>
</person-group>. <article-title>Prediction of coronary events with electron beam computed tomography</article-title>. <source>J Am Coll Cardiol</source>. <year>2000</year>;<volume>36</volume>(<issue>4</issue>):<fpage>1253</fpage>–<lpage>1260</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712454217">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Detrano</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Eisenberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gardin</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events</article-title>. <source>Am J Cardiol</source>. <year>2000</year>;<volume>86</volume>(<issue>5</issue>):<fpage>495</fpage>–<lpage>498</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712454217">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polonsky</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>McClelland</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Jorgensen</surname>
<given-names>NW</given-names>
</name>
<etal/>
</person-group>. <article-title>Coronary artery calcium score and risk classification for coronary heart disease prediction</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>16</issue>):<fpage>1610</fpage>–<lpage>1616</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712454217">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yalta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yalta</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yucel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sivri</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Extensive coronary arterial calcification: an over-adaptive phenomenon against complications of atherosclerosis?</article-title> <source>Int J Cardiol</source>. <year>2011</year>;<volume>146</volume>(<issue>2</issue>):<fpage>227</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712454217">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Leopold</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Loscalzo</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Vascular calcification: pathobiological mechanisms and clinical implications</article-title>. <source>Circ Res</source>. <year>2006</year>;<volume>99</volume>(<issue>10</issue>):<fpage>1044</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712454217">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Virmani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Younis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Kamm</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>RT</given-names>
</name>
</person-group>. <article-title>The impact of calcification on the biomechanical stability of atherosclerotic plaques</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>103</volume>(<issue>8</issue>):<fpage>1051</fpage>–<lpage>106</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712454217">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wayhs</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zelinger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raggi</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>High coronary artery calcium scores pose an extremely elevated risk for hard events</article-title>. <source>J Am Coll Cardiol</source>. <year>2002</year>;<volume>39</volume>(<issue>2</issue>):<fpage>225</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712454217">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budoff</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>ST</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients</article-title>. <source>J Am Coll Cardiol</source>. <year>2007</year>;<volume>49</volume>(<issue>18</issue>):<fpage>1860</fpage>–<lpage>1870</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712454217">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coylewright</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Buddoff</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis</article-title>. <source>Atherosclerosis</source>. <year>2011</year>;<volume>219</volume>(<issue>2</issue>):<fpage>616</fpage>–<lpage>622</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712454217">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agatston</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Janowitz</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Hildner</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Zusmer</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Viamonte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Detrano</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Quantification of coronary artery calcium using ultrafast computed tomography</article-title>. <source>J Am Coll Cardiol</source>. <year>1990</year>;<volume>15</volume>(<issue>4</issue>):<fpage>827</fpage>–<lpage>832</lpage>.</citation>
</ref>
<ref id="bibr17-0003319712454217">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Sheedy</surname>
<given-names>PF</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Breen</surname>
<given-names>JF</given-names>
</name>
<etal/>
</person-group>. <article-title>Detection of heart calcification with electron beam CT: interobserver and intraobserver reliability for scoring quantification</article-title>. <source>Radiology</source>. <year>1994</year>;<volume>190</volume>(<issue>2</issue>):<fpage>347</fpage>–<lpage>352</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712454217">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeda</surname>
<given-names>FQ</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Senter</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (≥1000) detected by electron beam computed tomography</article-title>. <source>Cardiovasc Radiat Med</source>. <year>2004</year>;<volume>5</volume>(<issue>3</issue>):<fpage>109</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr19-0003319712454217">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Quantification of regional calcium burden in chronic total occlusion by 64-slice multi-detector computed tomography and procedural outcomes of percutaneous coronary intervention</article-title>. <source>Int J Cardiol</source>. <year>2010</year>;<volume>145</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712454217">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fournier</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Florian</surname>
<given-names>F</given-names>
</name>
</person-group>, <article-title>Ballesteros SM. [Rotational atherectomy of a lesion in which stent expansion was limited by severe calcification]</article-title>. <source>Rev Esp Cardiol</source>. <year>2005</year>;<volume>58</volume>(<issue>7</issue>):<fpage>879</fpage>–<lpage>880</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712454217">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Teirstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Linnemeier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moses</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque</article-title>. <source>Cathet Cardiovasc Interv</source>. <year>2001</year>;<volume>52</volume>(<issue>2</issue>):<fpage>208</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712454217">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henein</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses</article-title>. <source>Int J Cardiol</source>. <year>2011</year>;<volume>153</volume>(<issue>1</issue>):<fpage>31</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712454217">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Budoff</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by noninvasive Imaging Research) study</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>54</volume>(<issue>14</issue>):<fpage>1258</fpage>–<lpage>1267</lpage>.</citation>
</ref>
<ref id="bibr24-0003319712454217">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beckman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ganz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Creager</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Ganz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kinlay</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Relationship of clinical presentation and calcification of culprit coronary artery stenoses</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2001</year>;<volume>21</volume>(<issue>10</issue>):<fpage>1618</fpage>–<lpage>1622</lpage>.</citation>
</ref>
<ref id="bibr25-0003319712454217">
<label>25</label>
<citation citation-type="book">
<collab collab-type="author">Trends in ischemic heart disease deaths—United States, 1990-1994</collab>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>1997</year>;<volume>46</volume>(<issue>7</issue>):<fpage>146</fpage>–<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr26-0003319712454217">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenlan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alpert</surname>
<given-names>JS</given-names>
</name>
</person-group>, <article-title>Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title>. <source>J Am Coll Cardiol</source>. <year>2010</year>;<volume>56</volume>(<issue>25</issue>):<fpage>e50</fpage>–<lpage>e103</lpage>.</citation>
</ref>
<ref id="bibr27-0003319712454217">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budoff</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Achenbach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blumethal</surname>
<given-names>RS</given-names>
</name>
<etal/>
</person-group>. <article-title>Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology</article-title>. <source>Circulation</source>. <year>2006</year>;<volume>114</volume>(<issue>16</issue>):<fpage>1761</fpage>–<lpage>1791</lpage>.</citation>
</ref>
<ref id="bibr28-0003319712454217">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koulaouzidis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Charisopoulou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Koulaouzidis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>T.</given-names>
</name>
</person-group> <article-title>Prevalence of noncalcified coronary plaque in patients with calcium score of 0: the silent enemy [published online April 12, 2012]</article-title>. <source>Angiology</source>. <year>2012</year>. <comment>PMID: 22492253</comment>.</citation>
</ref>
<ref id="bibr29-0003319712454217">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allison</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>CM</given-names>
</name>
</person-group>. <article-title>Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1)</article-title>. <source>Int J Cardiol</source>. <year>2005</year>;<volume>98</volume>(<issue>2</issue>):<fpage>325</fpage>–<lpage>330</lpage>.</citation>
</ref>
<ref id="bibr30-0003319712454217">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feuerstein</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Brazaitis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Zoltick</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Electron beam computed tomography screening of the coronary arteries: experience with 3,263 patients at Walter Reed Army Medical Center</article-title>. <source>Mil Med</source>. <year>2001</year>;<volume>166</volume>(<issue>5</issue>):<fpage>432</fpage>–<lpage>442</lpage>.</citation>
</ref>
<ref id="bibr31-0003319712454217">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raggi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cooil</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Friede</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Predictors of aortic and coronary artery calcium on a screening electron beam tomographic scan</article-title>. <source>Am J Cardiol</source>. <year>2003</year>;<volume>91</volume>(<issue>6</issue>):<fpage>744</fpage>–<lpage>746</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>